Prospects for human gene therapy.
Procedures have now been developed for inserting functional genes into the bone marrow of mice. The most effective delivery system at present uses retroviral-based vectors to transfer a gene into murine bone marrow cells in culture. The genetically altered bone marrow is then implanted into recipient animals. These somatic cell gene therapy techniques are becoming increasingly efficient. Their future application in humans should result in at least partial correction of a number of genetic disorders. However, the safety of the procedures must still be established by further animal studies before human clinical trials would be ethical.
D032761:Animal Experimentation; D001853:Bone Marrow; D003264:Containment of Biohazards; D004267:DNA Viruses / Q000235:genetics; D004274:DNA, Recombinant; D028744:Ethics Committees, Research; D004992:Ethics, Medical; D035082:Federal Government; D005786:Gene Expression Regulation; D005796:Genes; D030342:Genetic Diseases, Inborn / Q000628:therapy*; D005818:Genetic Engineering; D005822:Genetic Vectors; D033161:Government Regulation; D006801:Humans; D008845:Microinjections; D009876:Operon; D010957:Plasmids; D012190:Retroviridae / Q000235:genetics; D018570:Risk Assessment; D012867:Skin; D014158:Transcription, Genetic
D004274:DNA, Recombinant